CTI BioPharma
CTIC
#5699
Rank
C$1.63 B
Marketcap
C$12.40
Share price
0.00%
Change (1 day)
23.55%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : C$0.18 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are C$0.18 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$0.19 B122.51%
2021-12-31C$87.51 M276.86%
2020-12-31C$23.22 M-37.28%
2019-12-31C$37.02 M-26.32%
2018-12-31C$50.25 M3.03%
2017-12-31C$48.77 M-35.29%
2016-12-31C$75.37 M-43.94%
2015-12-31C$0.13 B115.31%
2014-12-31C$62.44 M15.1%
2013-12-31C$54.25 M33.82%
2012-12-31C$40.54 M16.43%
2011-12-31C$34.81 M-40.7%
2010-12-31C$58.71 M-36.85%
2009-12-31C$92.97 M-59.3%
2008-12-31C$0.22 B26.25%
2007-12-31C$0.18 B-23.59%
2006-12-31C$0.23 B-22.51%
2005-12-31C$0.30 B-0.48%
2004-12-31C$0.30 B3.56%
2003-12-31C$0.29 B31.04%
2002-12-31C$0.22 B-26.84%
2001-12-31C$0.30 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
C$87.85 B 46,695.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$117.24 B 62,348.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$109.84 B 58,410.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C$19.03 B 10,038.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$2.44 B 1,201.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$97.58 B 51,878.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$44.79 B 23,758.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel